Clinical Trial Consultants

AdjuTec Pharma enters phase I with novel AMR treatment

AdjuTec Pharma has launched a phase I clinical trial for its leading candidate, APC148, targeting a critical unmet need...

Intervju

Toleranzia contracts clinical CRO for phase I/IIa study of TOL2

Toleranzia is developing the lead candidate TOL2 for the treatment of the autoimmune...

All the pieces in place for Dicot during Q2

Uppsala-based Dicot continues to take decisive steps in...

Intervju

Dicot heads into summer with a strengthened team and cash flow

In August, Dicot is expected to take its largest...

Intervju

News roundup Tuesday, July 2

An editorial selection of today's Life Science news

News roundup Tuesday, September 12

An editorial selection of today's Life Science news